Italian Journal of Pediatrics

tracked for impact factor

Open Access Research

A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians

Nicolino Ruperto1*, Luigi Carozzino2, Roberto Jamone2, Federico Freschi2, Gianfranco Picollo2, Marcella Zera2, Ornella Della Casa Alberighi3, Enrica Salvatori4, Alessandra Del Vecchio4, Paolo Dionisio4 and Alberto Martini5

Author Affiliations

1 IRCCS G Gaslini, Pediatria II, Reumatologia, PRINTO, Genoa, Italy

2 Local Health Unit (Azienda Sanitaria Locale -ASL) 3 "Genovese", Genoa, Italy

3 IRCCS G Gaslini, Scientific Direction, Clinical Pharmacology and Pediatric Clinical Trials Office, Genoa, Italy

4 Headquarters Medical Department, ACRAF S.p.A, Rome, Italy

5 IRCCS G. Gaslini, Pediatria II, Reumatologia and Dipartimento di Pediatria, Università degli Studi di Genova, Genoa, Italy

For all author emails, please log on.

Italian Journal of Pediatrics 2011, 37:48 doi:10.1186/1824-7288-37-48

Published: 29 September 2011

Abstract

Background

To evaluate the analgesic effect and tolerability of paracetamol syrup compared to placebo and ketoprofen lysine salt in children with pharyngotonsillitis cared by family pediatricians.

Methods

A double-blind, randomized, placebo-controlled trial of a 12 mg/kg single dose of paracetamol paralleled by open-label ketoprofren lysine salt sachet 40 mg. Six to 12 years old children with diagnosis of pharyngo-tonsillitis and a Children's Sore Throat Pain (CSTP) Thermometer score > 120 mm were enrolled. Primary endpoint was the Sum of Pain Intensity Differences (SPID) of the CSTP Intensity scale by the child.

Results

97 children were equally randomized to paracetamol, placebo or ketoprofen. Paracetamol was significantly more effective than placebo in the SPID of children and parents (P < 0.05) but not in the SPID reported by investigators, 1 hour after drug administration. Global evaluation of efficacy showed a statistically significant advantage of paracetamol over placebo after 1 hour either for children, parents or investigators. Patients treated in open fashion with ketoprofen lysine salt, showed similar improvement in pain over time. All treatments were well-tolerated.

Conclusions

A single oral dose of paracetamol or ketoprofen lysine salt are safe and effective analgesic treatments for children with sore throat in daily pediatric ambulatory care.

Keywords:
paracetamol; ketoprofen lysine salt; placebo; randomized double blind clinical trial; family pediatricians